中药防治动脉粥样硬化的多向干预:从内皮保护到免疫调节
动脉粥样硬化是全球心血管病和死亡的重要危险因素,他汀类副作用限制其应用。本综述汇总中药单体(如黄连、三七中黄酮类)及复方通过调脂、改善内皮功能、抗氧化、抗炎免疫调节及凋亡等多途径抑制动脉粥样硬化的证据,为中药治疗提供新视角。
要点
- 中药单体与复方可多靶点抑制动脉粥样硬化进展。
- 黄连、三七等提取的天然黄酮类成分兼具调脂与抗炎作用。
- 中药干预涉及内皮保护、氧化应激、免疫炎症及凋亡等机制。
核心结论
- 中药单体及复方通过多向干预机制在动脉粥样硬化防治中具有显著潜力。
研究设计与样本
- 本文为综述,检索并汇总中药单体与复方抗动脉粥样硬化相关研究。
主要发现
- 黄连、三七等中药提取的天然黄酮类单体具有调脂和抑制炎症的作用。
- 中药单体可单用或与其他中药组成复方,多途径增强抗动脉粥样硬化疗效。
- 中药干预涉及调节血脂、改善内皮功能、减少氧化应激、调节炎症与免疫反应及细胞凋亡。
临床怎么用
- 临床可关注黄连、三七等来源的黄酮类单体及复方在动脉粥样硬化患者中的调脂抗炎应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atherosclerosis is a significant risk factor for developing cardiovascular disease and a leading cause of death worldwide. The occurrence of atherosclerosis is closely related to factors such as endothelial injury, lipid deposition, immunity, and inflammation. Conventional statins, currently used in atherosclerosis treatment, have numerous adverse side effects that limit their clinical utility, prompting the urgent need to identify safer and more effective therapeutic alternatives. Growing evidence indicates the significant potential of Chinese herbs in atherosclerosis treatment. Herbal monomer components, such as natural flavonoid compounds extracted from herbs like Coptis chinensis and Panax notoginseng, have been utilized for their lipid-lowering and inflammation-inhibiting effects in atherosclerosis treatment. These herbs can be used as single components in treating diseases and with other Chinese medicines to form herbal combinations. This approach targets the disease mechanism in multiple ways, enhancing the therapeutic effects. Thus, this review examines the roles of Chinese herbal medicine monomers and Chinese herbal compounds in inhibiting atherosclerosis, including regulating lipids, improving endothelial function, reducing oxidative stress, regulating inflammation and the immune response, and apoptosis. By highlighting these roles, our study offers new perspectives on atherosclerosis treatment with Chinese herbs and is anticipated to contribute to advancements in related research fields.
引用
- Li JN, Wang MY, Tan YR, et al. Multidirectional Intervention of Chinese Herbal Medicine in the Prevention and Treatment of Atherosclerosis: From Endothelial Protection to Immunomodulation. Am J Chin Med. 2024. PMID: 38798151. doi:10.1142/S0192415X24500381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。